Joseph A. DiMasi
About
In The Last Decade
Joseph A. DiMasi
70 papers receiving 7.8k citations
Hit Papers
Peers
Comparison fields: 5 of 182
- Economics and Econometrics 4.0k
- Molecular Biology 1.8k
- Computational Theory and Mathematics 1.5k
- Public Health, Environmental and Occupational Health 1.3k
- Immunology 1.0k
Countries citing papers authored by Joseph A. DiMasi
This map shows the geographic impact of Joseph A. DiMasi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph A. DiMasi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph A. DiMasi more than expected).
Fields of papers citing papers by Joseph A. DiMasi
This network shows the impact of papers produced by Joseph A. DiMasi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph A. DiMasi. The network helps show where Joseph A. DiMasi may publish in the future.
Co-authorship network of co-authors of Joseph A. DiMasi
This figure shows the co-authorship network connecting the top 25 collaborators of Joseph A. DiMasi. A scholar is included among the top collaborators of Joseph A. DiMasi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph A. DiMasi. Joseph A. DiMasi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 9 | |
| 4 | 16 | |
| 5 | 94 | |
| 6 | 3 | |
| 7 | Investigating investment in biopharmaceutical R&D | 3 |
| 8 | Innovation in the pharmaceutical industry: New estimates of R&D costs breakdown → | 1948 |
| 9 | 9 | |
| 10 | 68 | |
| 11 | 68 | |
| 12 | 118 | |
| 13 | The price of innovation: new estimates of drug development costs breakdown → | 2642 |
| 14 | RETURNS ON R&D FOR 1990s NEW DRUG INTRODUCTIONS | 6 |
| 15 | 40 | |
| 16 | 12 | |
| 17 | 19 | |
| 18 | 440 | |
| 19 | 37 | |
| 20 | The Wage Gradient in a Multi-Nucleated City | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.